Document Detail


Development and evaluation of tocopherol-rich argan oil-based nanoemulsions as vehicles possessing anticancer activity.
MedLine Citation:
PMID:  23030003     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
In recent years, diverse nanoemulsion vehicles (NEs) have been developed with vast potential for improving therapeutic index of clinically approved and experimental drugs. Using oils rich in omega-3 and omega-6 polyunsaturated fatty acids (PUFA), several promising nanoemulsion formulations have been developed recently for oral and systemic administration. The aim of our present work is to successfully develop and characterize optimized nanoemulsion platform, using the PUFA-rich argan oil that contain several important anti-inflammatory and antimitotic natural components. Using various emulsifying mixtures of polyethoxylated solutol HS-15 and polyethyleneglucol Vitamin E succinyl ester (TPGS), to form different NEs showing extended shelf-life stability. The physicochemical properties of prototype argan NEs were analyzed and utilizing a 32 full factorial design, followed by biocompatibility screen, using normal vascular myocytes and areolar fibroblasts. While 90-180 day stability of NEs correlated with TPGS:solutol surfactant blend ratios, adverse effects on integrity of test cultures were only noted at high TPGS content in the emulsifier system, exceeding 80%. Finally, the anti-proliferative efficacy of selected stable and acceptably biocompatible nanoscale TPGS-emulsified argan oil formulations was investigated using murine breast and colon carcinoma cells. The IC50 values of the combination of argan oil and TPGS (40-80% wt of emulsifiers) were 5-9 folds lower compared to TPGS-free and argan-oil free control NEs. Argan oil NE, stabilized with Vitamin E TPGS and solutol HS mixtures, demonstrated significant pro-apoptotic effect on both test cancer cell lines, indicating built-in anticancer properties for such NE platform, potentially enhancing overall antineoplastic effects of incorporated candidate chemotherapeutic agents.
Authors:
Melanie Jordan; Amy Nayel; Bill Brownlow; Tamer Elbayoumi
Related Documents :
23376733 - Oral administration of omega-7 palmitoleic acid induces satiety and the release of appe...
25093613 - Cytochrome p450 epoxygenase pathway of polyunsaturated fatty acid metabolism.
10527543 - A na(+)-dependent system a and asc-independent amino acid transport system stimulated b...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of biomedical nanotechnology     Volume:  8     ISSN:  1550-7033     ISO Abbreviation:  J Biomed Nanotechnol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-10-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230869     Medline TA:  J Biomed Nanotechnol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  944-56     Citation Subset:  IM    
Affiliation:
College of Pharmacy-Glendale, Department of Pharmaceutical Sciences, Midwestern University, Glendale Hall 236-14, 19555 N. 59th Avenue, Glendale, AZ 85308, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Development of a total temperature micro-volume blended incubating and hybridizing apparatus for DNA...
Next Document:  Zinc oxide nanoparticles impair the integrity of human umbilical vein endothelial cell monolayer in ...